Impact of Diabetes on the gut and salivary iga microbiomes

Eric L. Brown, Heather T. Essigmann, Kristi L. Hoffman, Noah W. Palm, Sarah M. Gunter, Joel M. Sederstrom, Joseph F. Petrosino, Goo Jun, David Aguilar, William B. Perkison, Craig L. Hanis, Herbert L. DuPont

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Mucosal surfaces like those present in the lung, gut, and mouth interface with distinct external environments. These mucosal gateways are not only portals of entry for potential pathogens but also homes to microbial communities that impact host health. Secretory immunoglobulin A (SIgA) is the single most abundant acquired immune component secreted onto mucosal surfaces and, via the process of immune exclusion, shapes the architecture of these microbiomes. Not all microorganisms at mucosal surfaces are targeted by SIgA; therefore, a better understanding of the SIgA-coated fraction may identify the microbial constituents that stimulate host immune responses in the context of health and disease. Chronic diseases like type 2 diabetes are associated with altered microbial communities (dysbiosis) that in turn affect immune-mediated homeostasis. 16S rRNA gene sequencing of SIgA-coated/uncoated bacteria (IgA-Biome) was conducted on stool and saliva samples of normoglycemic participants and individuals with prediabetes or diabetes (n = 8/group). These analyses demonstrated shifts in relative abundance in the IgA-Biome profiles between normoglycemic, prediabetic, or diabetic samples distinct from that of the overall microbiome. Differences in IgA-Biome alpha diversity were apparent for both stool and saliva, while overarching bacterial community differences (beta diversity) were also observed in saliva. These data suggest that IgA-Biome analyses can be used to identify novel microbial signatures associated with diabetes and support the need for further studies exploring these communities. Ultimately, an understanding of the IgA-Biome may promote the development of novel strategies to restructure the microbiome as a means of preventing or treating diseases associated with dysbiosis at mucosal surfaces.

Original languageEnglish
Article numbere00301-20
JournalInfection and Immunity
Issue number12
StatePublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020 American Society for Microbiology. All Rights Reserved.


  • Diabetes
  • IgA biome
  • Microbiome

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'Impact of Diabetes on the gut and salivary iga microbiomes'. Together they form a unique fingerprint.

Cite this